Radiofrequency-induced Thermo-chemotherapy Effect Versus a Second Course of Bacillus Calmette-Guérin or Institutional Standard in Patients with Recurrence of Non-muscle-invasive Bladder Cancer Following Induction or Maintenance Bacillus Calmette-Guérin Therapy (HYMN): A Phase III, Open-label, Randomised Controlled Trial.

No Thumbnail Available
Authors
Tan, W.S.
Panchal, A.
Buckley, L.
Devall, A. J.
Loubière, L. S.
Pope, A. M.
Feneley, M. R.
Cresswell, J.
Issa, R.
Mostafid, H.
Journal
European urology
Type
Journal Article
Publisher
Elsevier
Rights
Archived with thanks to European urology
There is no effective intravesical second-line therapy for non-muscle-invasive bladder cancer (NMIBC) when bacillus Calmette-Guérin (BCG) fails.
Citation
Radiofrequency-induced Thermo-chemotherapy Effect Versus a Second Course of Bacillus Calmette-Guérin or Institutional Standard in Patients with Recurrence of Non-muscle-invasive Bladder Cancer Following Induction or Maintenance Bacillus Calmette-Guérin Therapy (HYMN): A Phase III, Open-label, Randomised Controlled Trial. 2019 Jan;75(1):63-71 Epub 2019 Sep 28 Eur. Urol.
Note